Skip to content

Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents

Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00571571
Acronym
TFP-A
Enrollment
20
Registered
2007-12-12
Start date
2007-10-31
Completion date
2009-12-31
Last updated
2011-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Identity Pathology, Behavior Problems

Keywords

Identity difussion, Adolescent psychotherapy, Transference Focused Psychotherapy for Adolescents, Identity, Identity crisis, Identity pathology

Brief summary

Normal adolescence requires a successful resolution of identity crisis, which results in the development of satisfying relationships, success in school/work pursuits, and achievement of personal goals. Adolescents, who do not resolve this crisis, are at high risk for problems in those areas of functioning. Transference Focused Psychotherapy for Adolescents (TFP-A) is a treatment that specifically addresses these issues, permitting adolescents to develop satisfying friendships, more appropriate interactions with authority, and achieve realistic life goals. This study will evaluate the application of TFP-A, (a empirically validated treatment for adults with identity disturbance), to adolescents exhibiting the same behavioral and identity pathology. Subjects will be females; ages 14-21, with behaviors associated with identity problems, interpersonal difficulties with teachers, parents and/or peers, and live with their families. These adolescents will be randomly assigned to one of two treatment cells, TFP-A or Treatment as Usual (TAU). Subjects in TFP-A will receive weekly individual therapy for six months. The TAU group will receive standard individual therapy in the Outpatient Department. Both will receive medication as necessary. All subjects will participate in initial, weekly, and bi-monthly assessments during the six-month treatment period, and participate in a naturalistic follow-up study for an additional six months. Hypothesis: Adolescents with identity problems as seen in interpersonal, school, and/or family difficulties in the Transference Focused Psychotherapy for Adolescents (TFP-A) group will reduce these problem behaviors and improve management of their feelings and moods compared to adolescents with identity problems in the treatment as usual control group (TAU).

Interventions

BEHAVIORALPsychotherapy

Individual psychotherapy with parent collateral/psychoeducation as necessary.

Individual psychotherapy and family interventions (as needed)

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Female Adolescents, ages 14-21 2. A score of five out of nine critical items on the Borderline Personality Disorder Dimension Interview Scale. 3. Have interpersonal difficulties in school, family, and/or peer functioning. 4. Live at home with family. 5. Willingness to attend evaluation sessions and weekly, individual therapy.

Exclusion criteria

1. The presence of psychosis, substance dependence, non-verbal learning disability, antisocial behavior, and/or primary diagnoses of eating disorder, bipolar disorder, and obsessive-compulsive disorder. 2. The need for hospitalization for symptom management. 3. Significant cognitive impairment (Full Scale IQ \<85). 4. The presence of a life-threatening medical illness.

Design outcomes

Primary

MeasureTime frame
Reduction in interpersonal difficulties with parents, teachers, and/or peers. Improved management of their feelings and moods. Reduction in other problems behaviors (i.e. substance use, self-injurious behaviors)Subjects will be assessed at entry, 2 month, 4 months, 6 months, 8 months 10 months, and 12 months

Countries

United States

Contacts

Primary ContactAnna E Odom, Ph.D.
ano9021@med.cornell.edu914-997-5946
Backup ContactPamela A Foelsch, Ph.D.
212-213-9879

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026